Eric Rouvier

Title: Eric Rouvier: Innovator in Monoclonal Antibodies

Introduction

Eric Rouvier is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Rouvier's work has the potential to impact various medical applications.

Latest Patents

Rouvier's latest patents include innovative advancements in monoclonal antibodies targeting human CTLA-8 (IL-17A). His patents cover the human CTLA-8 protein, antibodies that specifically bind to this protein, and nucleic acids encoding human CTLA-8. Additionally, he has developed methods for using these molecules and diagnostic kits. Another patent focuses on nucleic acids encoding CTLA-8 and related reagents, including purified proteins, specific antibodies, and nucleic acids encoding the CTLA-8 antigen from mammals. These patents also provide methods for using the reagents and diagnostic kits.

Career Highlights

Throughout his career, Eric Rouvier has worked with prominent organizations, including Schering Corporation. His expertise in biotechnology has allowed him to contribute to significant advancements in the field.

Collaborations

Rouvier has collaborated with notable professionals in his field, including Pierre Golstein and Francois Fossiez. These collaborations have further enriched his research and development efforts.

Conclusion

Eric Rouvier is a distinguished inventor whose work in monoclonal antibodies has the potential to advance medical diagnostics and treatments. His contributions to biotechnology are noteworthy and continue to influence the industry.